Chitu Violeta, Biundo Fabrizio, Shlager Gabriel G L, Park Eun S, Wang Ping, Gulinello Maria E, Gokhan Şölen, Ketchum Harmony C, Saha Kusumika, DeTure Michael A, Dickson Dennis W, Wszolek Zbignew K, Zheng Deyou, Croxford Andrew L, Becher Burkhard, Sun Daqian, Mehler Mark F, Stanley E Richard
Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Cell Rep. 2020 Mar 3;30(9):3004-3019.e5. doi: 10.1016/j.celrep.2020.02.028.
CSF-1R haploinsufficiency causes adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Previous studies in the Csf1r mouse model of ALSP hypothesized a central role of elevated cerebral Csf2 expression. Here, we show that monoallelic deletion of Csf2 rescues most behavioral deficits and histopathological changes in Csf1r mice by preventing microgliosis and eliminating most microglial transcriptomic alterations, including those indicative of oxidative stress and demyelination. We also show elevation of Csf2 transcripts and of several CSF-2 downstream targets in the brains of ALSP patients, demonstrating that the mechanisms identified in the mouse model are functional in humans. Our data provide insights into the mechanisms underlying ALSP. Because increased CSF2 levels and decreased microglial Csf1r expression have also been reported in Alzheimer's disease and multiple sclerosis, we suggest that the unbalanced CSF-1R/CSF-2 signaling we describe in the present study may contribute to the pathogenesis of other neurodegenerative conditions.
集落刺激因子1受体(CSF-1R)单倍体不足会导致成人发病的伴有轴突球状体和色素性神经胶质细胞的白质脑病(ALSP)。先前在ALSP的Csf1r小鼠模型中的研究推测脑内Csf2表达升高起核心作用。在此,我们表明,通过防止小胶质细胞增生并消除大多数小胶质细胞转录组改变,包括那些指示氧化应激和脱髓鞘的改变,单等位基因缺失Csf2可挽救Csf1r小鼠的大多数行为缺陷和组织病理学变化。我们还显示,ALSP患者大脑中Csf2转录本及几种CSF-2下游靶点升高,证明在小鼠模型中确定的机制在人类中起作用。我们的数据为ALSP的潜在机制提供了见解。由于在阿尔茨海默病和多发性硬化症中也报道了CSF2水平升高和小胶质细胞Csf1r表达降低,我们认为我们在本研究中描述的不平衡的CSF-1R/CSF-2信号传导可能促成其他神经退行性疾病的发病机制。